TelyRx Holdings Inc. experienced a notable decline in its stock price during yesterday's trading session.
In yesterday's trading session, TelyRx Holdings Inc. (TELY.TO) saw its stock price drop by 4.44%, closing at CA$2.15. This decline raises questions about the company's current market performance and investor sentiment.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.83M
52W high
$4.25
52W low
$2.00
1W change
-4.26%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
82.1%
Annualized
90-Day Vol
97.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.80
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.03 | C$1.53 – C$2.69 |
| 60 trading days | C$1.91 | C$1.28 – C$2.85 |
| 90 trading days | C$1.80 | C$1.10 – C$2.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as TelyRx's recent performance indicates potential volatility and uncertainty in the biotech sector.
TelyRx's stock fell 4.44% yesterday
The market cap of TelyRx now stands at approximately CA$57 million, reflecting investor concerns over its recent performance.
Bull case
Despite the recent downturn, TelyRx has shown significant revenue growth in previous quarters. This suggests that the company could recover and achieve long-term growth.
Bear case
The stock's decline might indicate deeper issues within the company or the broader market. Investors should closely examine TelyRx's financial health and competitive position.
Advertisement
Market Performance Overview
TelyRx Holdings Inc. experienced a significant drop in its stock price during yesterday's session, closing at CA$2.15. The 4.44% decline is noteworthy, especially considering the company's recent revenue growth in prior quarters, which had previously generated optimism among investors.
Investor Sentiment and Future Outlook
The recent decline in TelyRx's stock may reflect broader investor sentiment regarding the biotech sector's volatility. With a market cap of approximately CA$57 million, the company is under scrutiny as investors weigh its potential for recovery against the backdrop of its financial performance. For more insights into TelyRx's financial results, see TelyRx Announces Year-End 2025 Financial Results and TelyRx Announces First Quarter 2026 Financial Results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
